Skip to content

Emotion Recognition in Benign Epilepsy of Childhood With Centro-Temporal Spikes (BECTS)

Facial Emotion Decoding in Benign Partial Epilepsy of Childhood With Centrotemporal Spikes

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03465566
Acronym
BECTS
Enrollment
200
Registered
2018-03-14
Start date
2018-11-01
Completion date
2020-03-01
Last updated
2018-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

BECTS, Epilepsy, Rolandic

Keywords

Emotion, Social cognition, Childhood epilepsy

Brief summary

The social processes depend on complex cognitive mechanisms, which involve mainly the frontal and temporal lobe regions. Patients with early onset frontal and temporal lobe lesions might later develop important deficits in social integration. Accordingly, children with early onset temporal lobe epilepsy (TLE) demonstrate altered emotion recognition.

Detailed description

Study design: Multicentre, Case-control study. Emotion recognition is a first step for the development of the capacity to judge the thoughts, intentions, and desires of others. In infants, the capacity to identify, distinguish, and interpret emotions is limited, but these processes are developing rapidly and innately during the first years of life, on the same neural bases as those described in adulthood. Children with BECTS show altered social behavior. In fact, deficit in social cognition could derive from brain dysfunction in the frontotemporal regions primarily affected in BECTS, since these regions are also viewed as playing an important role in social cognition and development of social skills. The investigators hypothesized that children with BECTS might have altered social cognitive skills and underlying neural networks.

Interventions

DIAGNOSTIC_TESTIDS;MMSPE;CDI 2;CBCL;tests of facial expression evaluation

Five pictures (including nonfacial features; i.e., hairs) were used for each emotion, giving a total of 25 trials.Stimuli consist of pictures of facial affect taken from the Ekman and Friesen series.

Sponsors

Neuromed IRCCS
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
6 Years to 11 Years
Healthy volunteers
Yes

Inclusion criteria

* children diagnosed with active BECTS (e.g. having at least one seizure with epileptiform abnormalities at EEG) * treated or not with anti-epileptic drugs; age range between 6 and 11 * infants who have not presented an epileptic seizure within 48 hours before the psychodiagnostic evaluation * patients with a sleep EEG recording; MMSPE (Mini Mental State Pediatric Examination) ≥23.3

Exclusion criteria

* mental retardation * presence of other neurological or severe neuropsychiatric disorders * atypical EEG pattern (awake or asleep)

Design outcomes

Primary

MeasureTime frameDescription
Rating of the arousal of facial expressionsan average of 1 yearA neuropsychologist will ask the subjects to evaluate arousal in terms of feeling of high-low energy/wakefulness/alertness by rating each stimulus on a 9-point scale.
Rating of the valence of facial expressionsan average of 1 yearA neuropsychologist will ask the subjects to evaluate valence in terms of feeling of high-low pleasantness-unpleasantness by rating each stimulus on a 9-point scale.
Number (total amount) of errors in facial emotion recognitionan average of 1 yearA neuropsychologist will sign the number of errors in recognizing each facial emotion expression
Rating of the intensity of facial expressionsan average of 1 yearA neuropsychologist will ask the subjects to rate (on a scale from 0 = not at all to 5 = very much) each stimulus with respect to the prototypical expression of that emotion

Secondary

MeasureTime frameDescription
EEG abnormality lateralization and facial emotion recognitionan average of 1 yearThe investigators will include in statistical analysis the side (dominant hemisphere vs. non-dominant) of EEGraphic abnormalities on awake/sleep recordings

Countries

Italy

Contacts

Primary ContactAlfredo D'Aniello, MD
alfredod@vodafone.it0039865929528
Backup ContactMarco De Risi, PhD
marcoderisi@inwind.it0039865929528

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026